aod 9604 vs 5 amino 1mq 5-amino-1mq human trial 5-amino-1mq human clinical trial AOD-9604 5 Amino 1MQ – Prime

This compound is not approved for medical, veterinary, or consumer use and is sold only for laboratory research purposes

However, the largest Phase IIb trial involving 536 participants failed to demonstrate statistically significant weight loss compared to placebo at the primary 12-week endpoint, leading to development termination in 2007

People with conditions such as pernicious anaemia or other absorption disorders may require regular Vitamin B12 injections

+ - Early Effects: Many patients notice initial changes-such as increased energy levels or a decrease in appetite-within the first 12 weeks of consistent use